Immunodetection of chorionic gonadotropin and its subunits in human nonfunctioning pituitary adenomas. 1994

K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
Institute of Endocrine Science, Hospital Maggiore, Milan, Italy.

Human nonfunctioning pituitary adenomas (NFPA) may produce CG in addition to the classical glycoprotein hormones (LH, FSH, and TSH). The aim of the present study was to localize LH beta, FSH beta, TSH beta, alpha-subunit (alpha SU), CG, and its beta-subunit (beta SU) in NFPA using a highly specific immunohistochemical technique. Nine NFPA, obtained at surgery, were processed for both electron microscopy and immunohistochemistry. Three tumors resulted oncocytomas, and six were null cell. Using an immunofluorescence technique, all tumors were positive for at least one glycoprotein; in particular, seven adenomas were markedly positive for CG beta, whereas only two were positive for the intact CG. No association among LH beta, FSH beta, and CG beta positivity could be demonstrated in the different adenomas. In the seven tumors positive for both CG beta and alpha SU, double fluorescence labeling demonstrated that six cases localized CG beta and alpha SU in different cells, but only one tumor showed the two subunits colocalized in the same cells. These data confirm that pituitary tumors synthesize both alpha SU and beta SU of glycoprotein hormones; in particular, the present study indicates that the majority of NFPA is able to synthesize CG, particularly its beta SU. Moreover, the localization of CG beta and alpha SU in different tumoral cells might account for the preferential expression of beta SU and alpha SU instead of the intact hormonal molecules in NFPA.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D005260 Female Females
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas

Related Publications

K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
July 1996, American journal of clinical pathology,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
January 2002, Pituitary,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
August 1986, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
February 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
March 1973, Nihon Naibunpi Gakkai zasshi,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
December 1997, Clinical chemistry,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
K Saccomanno, and A Spada, and M Bassetti, and P Gil-del-Alamo, and G Faglia
January 1984, Annales d'endocrinologie,
Copied contents to your clipboard!